Last reviewed · How we verify
NCT06874088
Clinical and Radiographic Outcomes of Pulpotomy in Teeth with Different Symptoms and Root Stages
NA trial testing Pulpotomy with Calcium Silicate-Based Bioceramics in Permanent Teeth in Reversible Pulpitis in 34 participants. Completed in 3 March 2025.
30 January 2025
Quick facts
| Lead sponsor | Muhammed Alagöz |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 34 |
| Start date | 25 May 2022 |
| Primary completion | 30 January 2025 |
| Estimated completion | 3 March 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Pulpotomy with Calcium Silicate-Based Bioceramics in Permanent Teeth
Conditions studied
- Reversible Pulpitis — all drugs for Reversible Pulpitis →
- Irreversible Pulpitis — all drugs for Irreversible Pulpitis →
- Mature Teeth — all drugs for Mature Teeth →
- Immature Teeth — all drugs for Immature Teeth →
Sponsor
Muhammed Alagöz
Who can join
Adults 7 to 14, any sex, with Reversible Pulpitis or Irreversible Pulpitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Pulpotomy is a vital pulp therapy (VPT) method used to maintain pulp vitality by removing inflamed or infected coronal pulp tissue while preserving the health and function of radicular pulp. This procedure supports root development in young permanent teeth and helps prevent long-term complications associated with apexogenesis. Recent studies indicate that pulpotomy can achieve success rates exceeding 90%, even in cases of symptomatic irreversible pulpitis, challenging traditional contraindications. Notably, this high success rate has been observed in both immature and mature permanent teeth, expanding the applicability of pulpotomy across different developmental stages. Modern materials such as Mineral Trioxide Aggregate (MTA) and Biodentine™ have been widely adopted in regenerative dentistry due to their biocompatibility and superior sealing properties. These materials are used effectively in both immature and mature teeth, contributing to the long-term success of vital pulp therapy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06874088
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Reversible Pulpitis
Currently open trials in the same condition.
- NCT07073573 — Evaluation of Pulpal Biomarkers in Vital Pulp Therapy · NA · active not recruiting
- NCT07391124 — In Vivo Pulp Thermal Changes During Different Slenderization Techniques · NA · active not recruiting
- NCT06844448 — The Effect of Different Risk Factors on the Success Rate of VPT · recruiting
- NCT06433297 — Comparative Evaluation of Indirect vs. Direct Pulp Capping in Deep Carious Mandibular Molars · NA · recruiting
- NCT07101068 — Assessment of Pain and Anxiety During Infiltration Anesthesia Using Dental Anesthesia Injector Versus Conventional Syrin · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06874088 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Muhammed Alagöz
- Last refreshed: 13 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06874088.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing